Suppr超能文献

去甲坡那定及其衍生物对α1A -肾上腺素能受体亚型选择性的一种可能结构决定因素。

A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.

作者信息

Madrero Y, Elorriaga M, Martinez S, Noguera M A, Cassels B K, D'Ocon P, Ivorra M D

机构信息

Departament de Farmacologia, Facultat de Farmacia, Universitat de València, Spain.

出版信息

Br J Pharmacol. 1996 Dec;119(8):1563-8. doi: 10.1111/j.1476-5381.1996.tb16073.x.

Abstract
  1. The selectivity of action of boldine and the related aporphine alkaloids, predicentrine (9-O-methylboldine) and glaucine (2,9-O-dimethylboldine) and alpha 1-adrenoceptor subtypes was studied by examining [3H]-prazosin competition binding in rat cerebral cortex. WB 4101 and benoxathian were used as selective alpha 1A-adrenoceptor antagonists. 2. In the competition experiments [3H]-prazosin (0.2 nM) binding was inhibited by WB 4101 and benoxathian. The inhibition curves displayed shallow slopes which could be subdivided into high and low affinity components (pKi = 9.92 and 8.29 for WB 4101, 9.35 and 7.94 for benoxathian). The two antagonists recognized approximately 37% of the sites with high affinity from among the total [3H]-prazosin specific binding sites. 3. Boldine, predicentrine and glaucine also competed for [3H]-prazosin (0.2 nM) binding with shallow and biphasic curves recognizing 30-40% of the sites with high affinity. Drug affinities (pKi) at the high and low affinity sites were, 8.31 and 6.50, respectively, for boldine, 8.13 and 6.39 for predicentrine, and 7.12 and 5.92 for glaucine. The relative order of selectivity for alpha 1A-adrenoceptors was boldine (70 fold alpha 1A-selective) = predicentrine (60 fold, alpha 1A-selective) > glaucine (15 fold, alpha 1A-selective). 4. Pretreatment of rat cerebral cortex membranes with chloroethylclonidine (CEC, 10 microM) for 30 min at 37 degrees C followed by thorough washing out reduced specific [3H]-prazosin binding by approximately 70%. The CEC-insensitive [3H]-prazosin binding was inhibited by boldine monophasically (Hill slope = 0.93) with a single pKi value (7.76). 5. These results suggest that whereas the aporphine structure shared by these alkaloids is responsible for their selectively of action for the alpha 1A-adrenoceptor subtype in rat cerebral cortex, defined functional groups, namely the 2-hydroxy function, induces a significant increase in alpha 1A-subtype selectivity and affinity.
摘要
  1. 通过检测大鼠大脑皮层中[3H] - 哌唑嗪竞争结合情况,研究了去甲乌药碱以及相关的阿朴啡生物碱、前胡碱(9 - O - 甲基去甲乌药碱)、青藤碱(2,9 - O - 二甲基去甲乌药碱)和α1 - 肾上腺素能受体亚型的作用选择性。WB 4101和贝诺沙嗪用作选择性α1A - 肾上腺素能受体拮抗剂。2. 在竞争实验中,[3H] - 哌唑嗪(0.2 nM)的结合被WB 4101和贝诺沙嗪抑制。抑制曲线呈浅斜率,可分为高亲和力和低亲和力组分(WB 4101的pKi分别为9.92和8.29,贝诺沙嗪的pKi分别为9.35和7.94)。这两种拮抗剂在总的[3H] - 哌唑嗪特异性结合位点中识别出约37%的高亲和力位点。3. 去甲乌药碱、前胡碱和青藤碱也竞争[3H] - 哌唑嗪(0.2 nM)的结合,曲线呈浅斜率且为双相,识别出30 - 40%的高亲和力位点。去甲乌药碱在高亲和力和低亲和力位点的药物亲和力(pKi)分别为8.31和6.50,前胡碱为8.13和6.39,青藤碱为7.12和5.92。对α1A - 肾上腺素能受体的选择性相对顺序为去甲乌药碱(对α1A选择性高70倍) = 前胡碱(对α1A选择性高60倍)>青藤碱(对α1A选择性高15倍)。4. 在37℃下用氯乙可乐定(CEC,10μM)预处理大鼠大脑皮层膜30分钟,然后彻底洗脱,使特异性[3H] - 哌唑嗪结合减少约70%。CEC不敏感的[3H] - 哌唑嗪结合被去甲乌药碱单相抑制(希尔斜率 = 0.93),单一pKi值为7.76。5. 这些结果表明,这些生物碱共有的阿朴啡结构决定了它们对大鼠大脑皮层中α1A - 肾上腺素能受体亚型的作用选择性,特定的官能团,即2 - 羟基官能团,可显著提高α1A亚型的选择性和亲和力。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验